| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
---|
Phase N/A 1
2 3 4 Trials | | 0 | 12345678910 |
---|
| | | |
---|
| | | |
---|
| | | |
---|
CAR19T2 T cells / Zhaotai InVivo Biomedicine | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, B7-H3 targeting CAR-TILs / Zhaotai InVivo Biomedicine | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
HER2, Mesothelin, PSCA, MUC1, Lewis-Y, GPC3, AXL, EGFR, Claudin18.2/6, ROR1, GD1, B7-H3 targeting TILs / Zhaotai InVivo Biomedicine | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
PSCA/MUC1/TGFβ/HER2/Mesothelin/Lewis-Y/GPC3/AXL/EGFR/B7-H3/Claudin18.2-CAR-T cells / Hunan Yongren Medical Innovation, Zhaotai InVivo Biomedicine | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
TGFβ targeting CAR-T cells / Hunan Yongren Medical Innovation, Zhaotai InVivo Biomedicine | | | |
---|
| |
---|
| |
---|
| | | |
---|
| | | |
---|
|